Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

L'Oreal Company ADR (OP:LRLCY)

83.30 +0.23 (+0.28%)
Streaming Delayed Price Updated: 3:00 PM EST, Nov 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about L'Oreal Company ADR

< Previous 1 2 Next >
E.L.F. Beauty's Rising Social Media Influence Boosts Prospects Despite Economic Uncertainties, Analyst Says
DA Davidson analyst Linda Bolton Weiser reiterated a Buy rating on the shares of E.L.F. 
Via Benzinga
3 Stocks to Buy for a Billionaire-Backed Portfolio
These three stocks with billionaire-backing all make sense to own over the long haul because they all eat their own cooking. 
Via InvestorPlace
European Stocks Slip As UK Inflation Accelerates, Central Bankers Remain Hawkish
Negative news flows are trickling out of Europe ahead of Wall Street's opening bell on Wednesday. All European stock indices traded deeply in the red, as investors panicked after a fresh acceleration... 
Via Benzinga
L'Oréal's Latest Acquisition Could Be a Game Changer
The cosmetics giant's purchase of Aēsop was its biggest acquisition ever. 
Via The Motley Fool
Russia Warns As Finland Joins NATO, Spotify Highlights Struggle With Live Audio, Anticompetitive Charges Against Activision Blizzard: Today's Top Stories
Benzinga Finland Joins NATO Doubling Border Length, Russia Issues Warning 
Via Benzinga
Is Now the Right Time to Buy L'Oréal Stock?
The French cosmetics giant isn't too worried about inflation. 
Via The Motley Fool
Natura Divests Aesop To L'Oréal For $2.5B; Plans To Focus On Strategic Priorities
 
Via Benzinga
L'Oréal Faces Several Lawsuits Against Its Hair Relaxer Products Claiming It Causes Cancer
L'Oreal SA (OTC: LRLCY) and other companies making hair relaxer products have been slapped with 57 lawsuits claiming the products cause cancer and other health problems. 
Via Benzinga
LVMH, L'Oréal Mull Stake In Cosmetics Brand Aesop: Report
 
Via Benzinga
Despite A 21% Decline In M&A Activity, 2022 Is Still Poised To Become Second-Best Year On Record
This year started off on rocky footing that’s made many investors nervous. 
Via Benzinga
The 5 Dos And Don'ts Of Preparing For An Exit As A Founder, According To M&A Experts
The global network of merger and acquisitions (M&A) experts at Exitwise have seemingly seen it all when it comes to founders and owners selling their businesses.  
Via Benzinga
The Valens Company Nominates Independent Director To Board Of Directors
The Valens Company Inc. 
Via Benzinga
High-Quality Growth From A Leader In Billionaire Brands
Back into favor in 2022 are the companies that have been almost forgotten by the market: strong companies growing steadily, no matter the economic conditions. One such is Nestle. 
Via Talk Markets
Sanofi To List Drug Ingredient Spin-Off EUROAPI On Euronext Paris in May
Sanofi SA (NASDAQ: SNY) plans to list its drug ingredients subsidiary EUROAPI on May 6, saying the business is set to grow and improve its profitability as a separate business. 
Via Benzinga
10 Stocks to Buy That Could Make You a Millionaire in 2022
After this past year, it's going to be hard to find stocks to buy to make you a millionaire in 2022. Here are 10 that might do the trick. 
Via InvestorPlace
Alphabet Unit Verily, L'Oreal Collaborate On Skin Health: What You Need To Know
Alphabet, Inc.'s (NASDAQ: GOOGL) (NASDAQ: GOOG) subsidiary Verily, a precision health company, and L'Oréal S.A. (Pink: LRLCY) announced Thursday a strategic... 
Via Benzinga
Zhihu's Revenue Rose 144% Year-on-Year
Key points: Zhihu’s revenue rose 144% year-on-year in its latest quarterly results, fueled by a big increase in ‘content commerce solutions’ One of the company... 
Via Benzinga
15 European Dividend Aristocrats To Diversify Your Portfolio
In general, Dividend Aristocrats are the foundation for the portfolios of most serious dividend growth investors. European Dividend aristocrats are typically blue chip stocks that... 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.